chang fair valu estim
updat forecast estim feb
conduct analyst
govern code ethics/cod conduct
polici secur trade polici
equival invest research
interest visit
primari analyst cover compani
stock
research feb
estim feb
price data
rate updat
currenc amount express
busi strategi outlook
methodolog valu compani
busi strategi outlook
zimmer leader hip knee reconstruct enjoy fruit
wide econom moat addit smaller competitor
biomet zimmer undisput king larg joint reconstruct
far expect favor demograph includ age
babi boomer rise obes fuel solid demand large-joint
replac off-set price declin howev zimmer
plagu pitfal sinc late includ
integr issu suppli inventori challeng qualiti
concern caught attent food drug
administr new manag tackl issu
firm pois ramp growth
zimmer benefit close relationship orthoped
surgeon make brand choic high switch cost
high-touch servic keep surgeon close tie primari
vendor surgeon bring enough profit procedur
keep hospit administr bay close relationship
vendor loyalti also explain market share shift orthoped
implant glacial best long zimmer launch
compar technolog within year rival remain
strong competit posit nevertheless think surgeon
influenc inevit erod practic medicin chang
respons healthcar reform long term
difficult surgeon run privat practic profit
open employ hospit
think grow emphasi payer hospit
compar effect cost-effect make
condit tougher zimmer rival natur
orthoped innov tend evolutionari rather
revolutionari also less common orthoped innov
tap untreat patient pool unmet need
strategi cardiac devic maker pursu success
difficulti ethic issu surround random control
trial orthoped also weaken zimmer posit
press premium price think achiev meaning
innov orthoped implant challeng
valuat summari forecast
financi summari forecast
historical/forecast data sourc morningstar estim may reflect adjust
zimmer biomet design manufactur market orthoped
reconstruct implant well suppli surgic equip
orthoped surgeri acquisit centerpuls biomet
zimmer hold lead share reconstruct market
unit state europ japan roughli total revenu deriv
sale larg joint anoth come extrem trauma
remain portion primarili relat spine dental product
morningstar right reserv unless otherwis provid separ agreement may use report countri origin distributor base inform data analys opinion present herein constitut
invest advic provid sole inform purpos therefor offer buy sell secur warrant correct complet accur opinion express date written subject chang without
notic except otherwis requir law shall respons trade decis damag loss result relat inform data analys opinion use inform contain herein
proprietari properti may reproduc whole part use manner without prior written consent invest research produc issu subsidiari inc includ limit
morningstar research servic llc regist govern secur exchang commiss order reprint call licens research call pleas see import disclosur end report
chang fair valu estim feb
zimmer biomet deliv solid fourth-quart result
built improv weve seen last
quarter consist expect
point leav fair valu estim
unchang havent made materi chang
assumpt project full year
fall within rang manag outlook fourth-
quarter revenu rose constant currenc fuel
strength knee -- account roughli total
revenu pleas see knee busi
strengthen progress unfold
underscor confid zimmer biomet wide
econom moat firm continu enjoy largest
share surgeon train instrument
switch cost high inventori level restor
sale rep sell servic surgeon without worri
certain product size would unavail
expect recent strength knee sustain
potenti acceler
zimmer biomet saw knee volum acceler
rang fourth quarter continu fall short
estim fourth-quart knee volum
growth ran double-digit howev soundli beat
zimmer biomet perform partial due
healthi inventori level think rosa robot also
signific factor drive roughli half global knee
growth fourth quarter practition interest robot
run high zimmer biomet robot option
surgeon chomp bit
robot compat favor tool
implant think demand sustain base
instal robot grow also hearten
manag plan expand salesforc surgeon
train bode well grow robot base
oper flub address firm turn
attent innov effici comfort
zimmer biomet plan new product includ
hip replac partial knee indic rosa
two enthusiast hip mainli
partial knee replac remain nich procedur
estim knee patient mani
need total knee replac long reach
life partial implant addit weve
recent seen gener interest use mako
hip consid zimmer biomet remain leader
hip implant think would see outsiz benefit
adopt total hip replac rosa
hand recogn zimmer biomet oxford unicondylar
knee wide use partial knee plu firm also
offer persona partial knee thu firm vest
interest adapt rosa work partial knee
surpris see zimmer biomet detail plan
wring cost effici
someth
manag discuss past effort
estim cost million million next
four year project deliv oper margin
least end period fall line
expect oper margin weve
seen oper margin rang --
fell move consid price
environ chang sinc critic current
manag revenue meaning innov seek
oper effici background zimmer
improv posit pleas see select present
zimmer biomet gain toehold turnaround
final zimmer biomet on-going regulatori saga
north campu facil doesnt look like end time
soon food drug administr recent conduct
anoth re-inspect manag indic
morningstar right reserv unless otherwis provid separ agreement may use report countri origin distributor base inform data analys opinion present herein constitut
invest advic provid sole inform purpos therefor offer buy sell secur warrant correct complet accur opinion express date written subject chang without
notic except otherwis requir law shall respons trade decis damag loss result relat inform data analys opinion use inform contain herein
proprietari properti may reproduc whole part use manner without prior written consent invest research produc issu subsidiari inc includ limit
morningstar research servic llc regist govern secur exchang commiss order reprint call licens research call pleas see import disclosur end report
growth price eros hover around
annual put knee growth line market
total revenu growth
compound annual
firm see benefit pull-through
higher-margin devic consum associ
rosa robot effort increas effici longer
term four year would put profit slightli short
zimmer histor level
assum zimmer cost equiti equival
rate return expect investor demand
averag sensit econom cycl rel
base averag volatil cash flow
extens orthoped product portfolio rate zimmer
uncertainti medium
bull case put zimmer valu per share
incorpor robust knee hip growth thank
better-than-expect volum gain fuel uptak
rosa robot smaller price declin along line
basi point per year result revenu growth
outpac market also assum averag annual
trauma along
mid-single-digit growth dental surgic product
zimmer abl resolv oper
regulatori issu push consolid oper margin
back beyond past peak level
extrem
bearish scenario estim zimmer worth
per share scenario see anem market adopt
rosa robot weaker large-joint implant product
pull-through declin
price almost
eight observ need address one hand
improv firm receiv
observ inspect conduct april
novemb respect mean
remedi facil like continu requir
manag attent spend firm move
right direct progress slow remedi
like wont complet year
increas fair valu estim per share
reflect expect zimmer
biomet match market growth larg joint
time frame optimist project
long-term growth think turnaround effort
begun take hold despit recent turbul
relat regulatori issu inventori mismanag
manag chang think zimmer biomet wide
econom moat remain intact sourc moat
chang materi underli dynam
orthoped market remain balanc favor
manufactur project knee volum reach
morningstar right reserv unless otherwis provid separ agreement may use report countri origin distributor base inform data analys opinion present herein constitut
invest advic provid sole inform purpos therefor offer buy sell secur warrant correct complet accur opinion express date written subject chang without
notic except otherwis requir law shall respons trade decis damag loss result relat inform data analys opinion use inform contain herein
proprietari properti may reproduc whole part use manner without prior written consent invest research produc issu subsidiari inc includ limit
morningstar research servic llc regist govern secur exchang commiss order reprint call licens research call pleas see import disclosur end report
complet off-set volum gain hip knee trauma
extrem dental surgic product remain
flat-to-declin zimmer oper margin peak
thank unfavor price
wholli off-set lower sale market spend
zimmer wide econom moat stem two major
sourc first substanti switch cost
orthoped surgeon extens instrument tool
set use prepar bone instal implant specif
compani learn curv becom profici
use one compani instrument signific
addit rel specialist orthoped
surgeon skill experi play outsiz role
clinic outcom patient issu leav
train master multipl
instrument system especi procedur volum
low maintain high surgic facil one
system surgeon prefer certain vendor
stretch back day resid train research
found surgeon stick prefer vendor
sale rep year use vendor
approxim orthoped procedur
time switch anoth instrument system
would requir take time train develop
relationship new sale rep work less effici
earli period master anoth vendor tool
possibl rais risk patient reduc
number procedur incom surgeon
dynam explain market share among four top
orthoped implant maker remain remark steadi
intellectu properti protect product portfolio
character evolutionari chang
technolog new gener product reli
intellectu properti establish earlier iter
devic follow chang patent law introduc
 switch first-inventor-to-fil
system previous first-to-inv system
think chang favor moat larger
inventor file applic soon possibl inventor
also need provid detail applic order
head competitor may block improv patent
futur gener product new law also
mandat opposit review patent
grant result challeng patent
think firm like zimmer support extens legal
team better posit take advantag
new law file comprehens patent applic
timelin mount complex
patent grant
think anoth intang asset relationship
sale rep surgeon
medic devic equip orthoped sale rep play
critic role surgeon sale rep present
everi procedur teach surgeon use tool
kit prepar select instrument
right size sequenc procedur accord
individu surgeon prefer orthoped
surgeon may perform hip replac
knee replac year sale rep provid
valuabl servic small group high-volum
surgeon may perform multipl knee
replac day less need train
sale rep surgeon may wish hire nurs
handl procedur prepar
think zimmer moat trend remain stabl despit
recent turbul due regulatori issu inventori
glitch new manag grasp rein think
morningstar right reserv unless otherwis provid separ agreement may use report countri origin distributor base inform data analys opinion present herein constitut
invest advic provid sole inform purpos therefor offer buy sell secur warrant correct complet accur opinion express date written subject chang without
notic except otherwis requir law shall respons trade decis damag loss result relat inform data analys opinion use inform contain herein
proprietari properti may reproduc whole part use manner without prior written consent invest research produc issu subsidiari inc includ limit
morningstar research servic llc regist govern secur exchang commiss order reprint call licens research call pleas see import disclosur end report
surgeon favor zimmer biomet product
past like give firm leeway address
obstacl disrupt reliabl suppli
product brand histor fall behind key
orthoped competitor even year
necessarili perman impair underli busi
recent competit activ around large-joint
replac driven indic expans
robot system includ total knee replac
mako robot smith nephew navio robot
reassur zimmer biomet rosa robot total
knee replac indic put firm strong
posit play catch next month rosa
robot give zimmer biomet leg orthoped stalwart
johnson johnson delay acquisit
type robot technolog like enter
market
although larger reimburs environ remain
tough expect on-going price pressur zimmer
biomet remain strong competit posit
combin compani access largest pool
surgeon train instrument -- estim
roughli total hip knee surgeon think
size combin surgeon pool along high
switch cost orthoped virtual guarante
zimmer nearli everi hospit vendor list
replac medicar
payer whittl away reimburs joint
reconstruct procedur demand expect
rise first babi boomer reach key age window
reimburs surgeon hip knee replac
procedur introduc bundl payment hip/kne
replac implant account
approxim half procedur reimburs
medicar zimmer find much difficult justifi
price increas reimburs remain pressur
erod reimburs also mean orthoped
procedur histor profit-cent
hospit less profit also suggest
orthoped surgeon could less influenc
hospit institut shift cardiovascular
neurosurgeri outsiz profit contribut
longer term zimmer histor relianc
surgeon relationship could serious weaken firm
econom moat triangul relationship among
physician hospit payer zimmer biomet
histor thrown lot surgeon make
brand choic histor posit
align zimmer biomet surgeon typic
free agent could practic hospit long
orthoped surgeon brought profit procedur
hospit held sway relationship
hospit defer orthoped procedur
profit hospit
greater pressur manag profit hospit
administr assert bring cost
includ implant control
howev suggest orthoped surgeon
eager go along chang think
weaken surgeon influenc autonomi take
place gradual long time frame unlik primary-car
practition cardiologist repres
highest proport specialist sign
hospit healthcar system employe orthoped
surgeon repres last holdout privat practic
current orthoped surgeon salari
hospit system half still privat practic
long haul proport employe orthoped
surgeon undoubtedli grow gener
chang consid current rate convers
morningstar right reserv unless otherwis provid separ agreement may use report countri origin distributor base inform data analys opinion present herein constitut
invest advic provid sole inform purpos therefor offer buy sell secur warrant correct complet accur opinion express date written subject chang without
notic except otherwis requir law shall respons trade decis damag loss result relat inform data analys opinion use inform contain herein
proprietari properti may reproduc whole part use manner without prior written consent invest research produc issu subsidiari inc includ limit
morningstar research servic llc regist govern secur exchang commiss order reprint call licens research call pleas see import disclosur end report
take year orthoped surgeon reach
level hospit employ cardiologist
alreadi reach meantim orthoped surgeon
remain highli independ enjoy autonomi
increas incom fee-for-servic framework resist
hospit effort limit brand choic mani
attempt hospit made rein
analysi team formulari model -- mostli fail
face healthcar reform stake hospit
rais continu chip away
issu pilot account care organ
bundl reimburs grow
pressur orthoped surgeon
accommod
cost-contain measur could limit brand
choic medicar continu cut physician fee
joint replac orthoped surgeon may decid
better hospit employe would
acceler consolid brand choic hand
administr
morningstar right reserv unless otherwis provid separ agreement may use report countri origin distributor base inform data analys opinion present herein constitut
invest advic provid sole inform purpos therefor offer buy sell secur warrant correct complet accur opinion express date written subject chang without
notic except otherwis requir law shall respons trade decis damag loss result relat inform data analys opinion use inform contain herein
proprietari properti may reproduc whole part use manner without prior written consent invest research produc issu subsidiari inc includ limit
morningstar research servic llc regist govern secur exchang commiss order reprint call licens research call pleas see import disclosur end report
oceo bryan hanson made substanti stride
meld two cultur zimmer biomet
togeth think charismat leadership
especi motiv salesforc
oorthoped surgeon often resist effort hospit
health system limit autonomi brand
choic one major factor contribut
consist failur program put forth
provid
oth scarciti high-qual compar effect
research data make difficult orthoped
compani secur premium price time
payer hospit rais bar cost-
opportun custom also mean
complic
ozimm amass impress portfolio
patent own control approxim
issu patent applic world-wide
 could put pressur zimmer
continu shoulder consider cost high-
morningstar right reserv unless otherwis provid separ agreement may use report countri origin distributor base inform data analys opinion present herein constitut
invest advic provid sole inform purpos therefor offer buy sell secur warrant correct complet accur opinion express date written subject chang without
notic except otherwis requir law shall respons trade decis damag loss result relat inform data analys opinion use inform contain herein
proprietari properti may reproduc whole part use manner without prior written consent invest research produc issu subsidiari inc includ limit
morningstar research servic llc regist govern secur exchang commiss order reprint call licens research call pleas see import disclosur end report
equival begin period
total avail debt servic
oblig commit
total oblig commit
adjust free
gener
gener revolv adjust
commit
think zimmer biomet fine financi shape
easili shoulder debt oblig leav dri powder
acquisit continu pay small dividend
follow acquisit biomet firm
consist de-lever -- pay debt
billion end anticip substanti
de-lever septemb gross debt
stood billion roughli time ebitda
consider improv sinc acquisit
biomet left firm debt/adjust
ebitda time put leverag close
manag goal gross debt/ebitda time
base averag volatil cash flow
extens orthoped product portfolio rate zimmer
biomet uncertainti medium zimmer biomet
near-term risk bound regulatori infract
fda document number qualiti control
issu seriou perspect issu
resolv time manner product may
risk fda decid interven hold market
product pipelin candid regulatori review
zimmer biomet taken step restor adequ
inventori level order sale rep effect
appeal orthoped surgeon slip-up could
slow sale think surgeon recept
rosa robot anoth near-term risk practition
embrac zimmer biomet robot array featur
differ mako robot
hinder firm abil catch
instal base robot product pull-through
strateg risk zimmer manag team
come
chang orthoped
environ although chang unfold slowli
write wall bundl payment surgeon join
grip
morningstar right reserv unless otherwis provid separ agreement may use report countri origin distributor base inform data analys opinion present herein constitut
invest advic provid sole inform purpos therefor offer buy sell secur warrant correct complet accur opinion express date written subject chang without
notic except otherwis requir law shall respons trade decis damag loss result relat inform data analys opinion use inform contain herein
proprietari properti may reproduc whole part use manner without prior written consent invest research produc issu subsidiari inc includ limit
morningstar research servic llc regist govern secur exchang commiss order reprint call licens research call pleas see import disclosur end report
hospit employe transpar price
come pike manag
formul new model orthoped product zimmer
could left dust meantim firm
vulner product recal relat legal fee
inventori write-off regulatori payer push
devic registri orthoped compani may subject
frequent discoveri product failur
consum spend pattern increas cost-shar
requir push out-of-pocket expens onto
morningstar right reserv unless otherwis provid separ agreement may use report countri origin distributor base inform data analys opinion present herein constitut
invest advic provid sole inform purpos therefor offer buy sell secur warrant correct complet accur opinion express date written subject chang without
notic except otherwis requir law shall respons trade decis damag loss result relat inform data analys opinion use inform contain herein
proprietari properti may reproduc whole part use manner without prior written consent invest research produc issu subsidiari inc includ limit
morningstar research servic llc regist govern secur exchang commiss order reprint call licens research call pleas see import disclosur end report
repres date owner name posit common share held report holder issuer
share
fund
share
fund
zimmer stewardship standard reflect former ceo
david dvorak tenur helm bryan hanson
step ceo role remain earli assess
chang firm plan capit alloc
nonetheless fan hanson previou perform
covidien although delv
orthoped market past deep
understand competit dynam medic
technolog good handl hospit client
leadership skill ralli employe base
struggl cultur two legaci compani come
togeth thu far pleas hanson
prioriti systemat approach address myriad
issu hinder zimmer biomet result yet
fulli manifest financi perform
optimist evid improv flow
next month
dvorak leadership zimmer biomet commit
acquir technolog execut number
tuck-in purchas substanti larger purchas
biomet isol event expect
scale acquisit regular basi firm
biomet purchas last coupl year
howev note someth commonli seen
zimmer biomet longer histori
seen hint manag strateg vision
partner close orthoped surgeon
intern innov small acquisit technolog
help practition address wider span potenti
treatment orthoped patient hanson suggest
firm keep eye potenti tuck-in
purchas plenti opportun innov
intern well hanson helm think
like zimmer biomet -- firm gener stuck
knit focus develop large-joint
morningstar right reserv unless otherwis provid separ agreement may use report countri origin distributor base inform data analys opinion present herein constitut
invest advic provid sole inform purpos therefor offer buy sell secur warrant correct complet accur opinion express date written subject chang without
notic except otherwis requir law shall respons trade decis damag loss result relat inform data analys opinion use inform contain herein
proprietari properti may reproduc whole part use manner without prior written consent invest research produc issu subsidiari inc includ limit
morningstar research servic llc regist govern secur exchang commiss order reprint call licens research call pleas see import disclosur end report
replac franchis -- expand horizon bit
set sight nich within orthoped offer
potenti innov growth would put
firm stronger foot past take
advantag faster growth trauma extrem
beaten johnson johnson stryker
past
morningstar right reserv unless otherwis provid separ agreement may use report countri origin distributor base inform data analys opinion present herein constitut
invest advic provid sole inform purpos therefor offer buy sell secur warrant correct complet accur opinion express date written subject chang without
notic except otherwis requir law shall respons trade decis damag loss result relat inform data analys opinion use inform contain herein
proprietari properti may reproduc whole part use manner without prior written consent invest research produc issu subsidiari inc includ limit
morningstar research servic llc regist govern secur exchang commiss order reprint call licens research call pleas see import disclosur end report
zimmer biomet pois acceler growth larg
joint thank turnaround effort jan
think zimmer biomet turnaround take hold
moder rais fair valu estim per
share reflect optimist expect
long-term growth three year ago wide-moat firm
fell tailspin follow tangl food
drug administr defici supply-chain
inform system led product shortag face
challeng put stress organ
legaci biomet zimmer workforc devolv
step ceo role tackl chao zimmer
biomet inventori restor appropri level
manufactur facil remedi come close
firm readi play catch-up placement
seen orthoped devic maker
stumbl occas zimmer biomet weather type
situat well wide econom moat
stem high switch cost among orthoped
surgeon consist industri histori firm recent
train instrument devic
perspect even market share rival
abl gain past three year coincid
commerci mako robot remain
modest absolut level moreov skeptic
gain durabl zimmer biomet
launch rosa robot
detail discuss zimmer biomet
toehold turnaround
detail discuss orthoped robot pleas
see page robot invad orthoped
zimmer biomet benefit intern strength
pois acceler growth
zimmer biomet post strong third-quart result
remain track meet temper expect
full year hold steadi fair valu estim
last coupl quarter weve seen sign zimmer
biomet stabil address inventori issu heal
cultur rift prepar launch rosa went
long way toward steadi ship though manag
wide-moat compani took pain manag analyst
expect think zimmer biomet reach
inflect point well posit return
growth continu think zimmer biomet leader
larg joint reconstruct actual exceed market
growth longer term also recogn recoveri
could see fit start come quarter
similar johnson johnson third quarter strength
revenu growth constant currenc unlik
zimmer biomet also post decent sale growth
knee america region downright
impress robust quarterli volume/mix gain
knee hip respect
howev still see bright prospect acceler
growth zimmer biomet larg joint midterm
first knee perform strongli
outsid expect rachet knee
growth zimmer biomet surgeon becom confid
avail entir product portfolio
innov persona revis knee roll
rosa robot instal second price
eros larg joint third quarter continu trail
orthoped price eros seen
time frame improv
morningstar right reserv unless otherwis provid separ agreement may use report countri origin distributor base inform data analys opinion present herein constitut
invest advic provid sole inform purpos therefor offer buy sell secur warrant correct complet accur opinion express date written subject chang without
notic except otherwis requir law shall respons trade decis damag loss result relat inform data analys opinion use inform contain herein
proprietari properti may reproduc whole part use manner without prior written consent invest research produc issu subsidiari inc includ limit
morningstar research servic llc regist govern secur exchang commiss order reprint call licens research call pleas see import disclosur end report
saw first half expect
progress rosa robot placement gradual lead
greater pull-through higher-margin cementless knee
morningstar right reserv unless otherwis provid separ agreement may use report countri origin distributor base inform data analys opinion present herein constitut
invest advic provid sole inform purpos therefor offer buy sell secur warrant correct complet accur opinion express date written subject chang without
notic except otherwis requir law shall respons trade decis damag loss result relat inform data analys opinion use inform contain herein
proprietari properti may reproduc whole part use manner without prior written consent invest research produc issu subsidiari inc includ limit
morningstar research servic llc regist govern secur exchang commiss order reprint call licens research call pleas see import disclosur end report
financi summari forecast
fiscal year end decemb
earn interest tax
return asset
return equiti
valuat summari forecast
equiti
pre-tax debt
weight averag capit
addit estim scenario avail download http //select morningstar com
equival
data tabl repres base-cas forecast compani report
currenc begin current year fair valu estim may differ
equiti valu per share shown due time valu money adjust case
probability-weight scenario analysi perform
morningstar right reserv unless otherwis provid separ agreement may use report countri origin distributor base inform data analys opinion present herein constitut
invest advic provid sole inform purpos therefor offer buy sell secur warrant correct complet accur opinion express date written subject chang without
notic except otherwis requir law shall respons trade decis damag loss result relat inform data analys opinion use inform contain herein
proprietari properti may reproduc whole part use manner without prior written consent invest research produc issu subsidiari inc includ limit
morningstar research servic llc regist govern secur exchang commiss order reprint call licens research call pleas see import disclosur end report
fiscal year end decemb
good sold
depreci amort report separ
impair charg report separ
morningstar right reserv unless otherwis provid separ agreement may use report countri origin distributor base inform data analys opinion present herein constitut
invest advic provid sole inform purpos therefor offer buy sell secur warrant correct complet accur opinion express date written subject chang without
notic except otherwis requir law shall respons trade decis damag loss result relat inform data analys opinion use inform contain herein
proprietari properti may reproduc whole part use manner without prior written consent invest research produc issu subsidiari inc includ limit
morningstar research servic llc regist govern secur exchang commiss order reprint call licens research call pleas see import disclosur end report
